Eribulin

Dosage Form	Solution for injection
Strength	0.44 mg/ml
Strength per Unit	0.88 mg/2 ml, 1.32 mg/3 ml
ATC Code	L01XX41
Drug Class	Other antineoplastic agents
Indication	Eribulin EVER Pharma is indicated for the treatment of adult patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. Prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting unless patients were not suitable for these treatments. Eribulin EVER Pharma is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease.
CytoWrap®	Vials may be sheathed in a protective sleeve.

Eribulin EVER Pharma is a prescription medication. Information for healthcare professionals only.
See the Summary of Product Characteristics for full information about the medication.